The EVIDENCE 360: RWE, Pricing & Reimbursement Summit Europe is scheduled for May 26-27, 2025, in Frankfurt, Germany. EVIDENCE 360 is a premier Real World Evidence Conference in Europe, bringing together industry leaders, regulatory experts, and healthcare professionals to explore the evolving landscape of RWE. As a key platform for discussion, RWE EVIDENCE 360 focuses on the integration of real-world data into healthcare decision-making, pricing strategies, and reimbursement frameworks.

This real-world evidence conference addresses critical challenges in data analytics, regulatory acceptance, and health technology assessments, making it a must-attend event for stakeholders involved in market access, value-based pricing, and policy development. The real-world evidence Reimbursement Summit Europe provides insights into regional disparities, innovative pricing models, and patient-centered approaches to optimize healthcare outcomes across the continent.

Key Topics

The summit will address several critical areas, including:

·       Data Analytics Tools: Exploring how artificial intelligence, machine learning, and big data are shaping the future of RWE analysis and usage.

·       Regional Disparities in Reimbursement Policies: Discussing the need for harmonization of pricing models across Europe to manage regional differences.

·       Regulatory Challenges: Navigating issues surrounding RWE data acceptance, standardization, and quality control in European markets.

·       Patient-Centered Data: Leveraging patient-reported outcomes to better address unmet needs and optimize healthcare access.

·       RWE and Health Technology Assessments (HTAs): Understanding how RWE influences HTAs in Europe, focusing on improving alignment between pricing, reimbursement decisions, and clinical effectiveness.

·       Personalized Medicine: Examining the future of personalized medicine and its impact on pricing and reimbursement.

Why Attend?

Attendees will gain valuable insights into:

·       The latest RWE trends and their influence on pricing and reimbursement strategies in Europe.

·       Networking opportunities with key industry leaders and regulators shaping the future of healthcare policy and market access.

·       The role of RWE in regulatory decision-making and its impact on health technology assessments.

·       The integration of AI and digital health in driving more efficient and effective reimbursement decisions.

·       Collaborative approaches to overcoming challenges in integrating RWE and enhancing patient outcomes through data-driven decisions.

For more information and to register for the real-world evidence conference at https://veridonglobal.com/events/evidence-360-rwe-pricing-reimbursement-summit-europe/evidance-360-registration/

Target Audience

This summit is designed for:

·       Executives, decision-makers, and researchers from pharmaceutical and biotech companies involved in drug development, market access, and pricing strategies.

·       Representatives from healthcare authorities, regulatory bodies, and health technology assessment agencies across Europe.

·       Researchers utilizing RWE to assess treatment outcomes, improve healthcare models, and support regulatory submissions.

·       Advisors and payers providing guidance on pricing strategies, reimbursement, and RWE implementation.

·       Investors interested in funding innovation in healthcare, particularly in RWE and value-based pricing models.